In this study, we intended to 1) recognize novel missense GRN mutations in one sporadic patient with FTD by cDNA sequencing; 2) define their clinical phenotypes and heterogeneity; and 3) summarize various FTD clinical phenotypes with different novel GRN mutations through literature review. This evidence concerns the gene GRN and frontotemporal dementia.